0001576280-24-000172.txt : 20240702
0001576280-24-000172.hdr.sgml : 20240702
20240702165826
ACCESSION NUMBER: 0001576280-24-000172
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240701
FILED AS OF DATE: 20240702
DATE AS OF CHANGE: 20240702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Saia John G.
CENTRAL INDEX KEY: 0001737840
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38683
FILM NUMBER: 241096640
MAIL ADDRESS:
STREET 1: C/O ACELRX PHARMACEUTICALS, INC.
STREET 2: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER NAME:
FORMER CONFORMED NAME: Saia John
DATE OF NAME CHANGE: 20180417
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Guardant Health, Inc.
CENTRAL INDEX KEY: 0001576280
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 454139254
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3100 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
BUSINESS PHONE: 855-698-8887
MAIL ADDRESS:
STREET 1: 3100 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
4
1
wk-form4_1719953898.xml
FORM 4
X0508
4
2024-07-01
0
0001576280
Guardant Health, Inc.
GH
0001737840
Saia John G.
3100 HANOVER STREET
PALO ALTO
CA
94304
0
1
0
0
Chief Legal Officer
0
Common Stock
2024-07-01
4
M
0
974
0
A
29391
D
Common Stock
2024-07-01
4
F
0
348
28.26
D
29043
D
Restricted Stock Units
0
2024-07-01
4
M
0
974
0
D
Common Stock
974
8766
D
These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
Not applicable for Restricted Stock Units.
/s/ John G. Saia
2024-07-02